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Mechanisms of gender-specific synaptic plasticity in the striatum, a brain region that controls motor, 
cognitive and psychiatric functions, remain unclear. Here we report that Rhes, a GTPase enriched 
in medium spiny neurons (MSNs) of striatum, alters the striatal cAMP/PKA signaling cascade in a 
gender-specific manner. While Rhes knockout (KO) male mice, compared to wild-type (WT) mice, had 
a significant basal increase of cAMP/PKA signaling pathway, the Rhes KO females exhibited a much 
stronger response of this pathway, selectively under the conditions of dopamine/adenosine-related 
drug challenge. Corticostriatal LTP defects are exclusively found in A2AR/D2R-expressing MSNs of 
KO females, compared to KO males, an effect that is abolished by PKA inhibitors but not by the 
removal of circulating estrogens. This suggests that the synaptic alterations found in KO females 
could be triggered by an aberrant A2AR/cAMP/PKA activity, but not due to estrogen-mediated effect. 
Consistent with increased cAMP signaling, D1R-mediated motor stimulation, haloperidol-induced 
catalepsy and caffeine-evoked hyper-activity are robustly enhanced in Rhes KO females compared 
to mutant males. Thus Rhes, a thyroid hormone-target gene, plays a relevant role in gender-specific 
synaptic and behavioral responses.
The Ras homolog enriched in striatum (Rhes) is a small GTP-binding protein discovered by subtractive 
hybridization1 and highly expressed throughout the dorsal striatum and nucleus accumbens of rodent 
brain2–4. Rhes transcription is regulated by thyroid hormones during development4–7 and by dopamine 
(DA) in the adult rat brain8.
Early studies in cell lines3,9 indicated that Rhes, most likely by binding to Gαi, reduces G-protein-coupled 
receptor (GPCR)-mediated accumulation of cAMP10. Accordingly, Rhes knockout (KO) mice have 
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increased striatal cAMP/PKA activity2. In addition to its influence on cAMP accumulation, Rhes acts 
as a selective striatal E3-ligase of mutant huntingtin, the sumoylation of which promotes neurotoxic-
ity11–13. These in vitro observations together with in vivo findings14 are consistent with the hypothesis that 
Rhes-mediated functions are common striatal targets for selective neurodegeneration in basal ganglia 
disorders15.
Consistently, it has been found that Rhes mediates AKT-mediated signaling16,17, participates in intra-
cellular iron homeostasis18 and, most notably, modulates mammalian target of rapamycin complex 1 
(mTORC1). This critical pathway is associated, among other processes19, with L-DOPA-induced dyski-
nesia (LID) in animal models of Parkinson disease20,21. These findings support the hypothesis that puta-
tive anti-Rhes drugs may attenuate the neurological manifestations of Huntington disease and LID22,23. 
Despite its growing role in striatal pathologies, the function of Rhes GTPase in striatal physiology 
remains less understood.
Previous studies indicated that lack of Rhes resulted in sex–sensitive behavioral phenotypes in 
mutants24,25, but the mechanisms are unknown. Here we dissected the mechanisms of the gender-specific 
differences associated to Rhes deletion, focusing on striatal cAMP/PKA-dependent signaling and tested 
the differential motor responses elicited by DA and adenosine agonist/antagonists. Overall, our study 
indicates that Rhes orchestrates gender-sensitive alterations in striatal signaling, synaptic plasticity, and 
behavioral responses.
Results
Rhes mRNA expression in GABAergic medium spiny neurons of mouse and human stria-
tum. To identify the striatal neurons that express Rhes, we performed double in situ-hybridization 
(ISH) on coronal sections along the rostro-caudal extent of the striatum of wild-type (WT) mouse brains 
(Fig. 1A–C). As a marker of GABAergic medium spiny neurons (MSNs) we used protein phosphatase 1 
regulatory subunit 1B (PPP1R1B), also known as Darpp32, a bifunctional signal transduction molecule, 
whose phosphorylation and function is regulated by dopaminergic and adenosine receptor stimulation26. 
As expected, Rhes expression was observed in virtually all Darpp32-positive striatal neurons, correspond-
ing to the projecting MSNs (Fig.  1D–G, arrows). Then, we performed double ISH using RASD2 and 
PPP1R1B riboprobes, respectively Rhes and Darpp32 human orthologs, to analyze mRNA distribution 
of this GTPase in the MSNs of human striatum (Fig. 1H,I). Consistent with the results in mouse brain, 
we found that RASD2 mRNA was highly enriched in the putamen nucleus and expressed in virtually all 
the PPP1R1B-positive projecting MSNs (Fig. 1I, arrows).
Lack of Rhes unmasks a gender-dependent modulation of striatal cAMP/PKA signaling. In 
order to evaluate whether the lack of Rhes modulates cAMP/PKA signaling in a gender-specific man-
ner. we analyzed the phosphorylation state of a selective PKA substrate, the glutamate AMPA receptor 
subunit at Ser845 residue (p-Ser845-GluA1)27, in both male and female mutants versus their matched 
controls, under basal and challenged conditions. Administration of SKF 81297, a DA D1R full ago-
nist, increased p-Ser845-GluA1 levels in males of both genotypes (Fig. 2A, left panel; two-way ANOVA, 
treatment effect: F(1,32) = 29.844, p < 0.0001). Although SKF 81297 induced an apparently higher striatal 
p-Ser845-GluA1 level in mutants (p = 0.0145, Fisher’s post-hoc), its relative increase compared to baseline 
(expressed as fold-induction) was similar to WT animals (Fig. 2A, right panel). This observation suggests 
that lack of Rhes in males mainly perturbs striatal tonic cAMP/PKA activity, as indicated by the sig-
nificantly higher basal p-Ser845-GluA1 levels in KO striata (p = 0.0092, Fisher’s post-hoc). Consistently, 
haloperidol, by unmasking the A2AR/cAMP/PKA-dependent signaling28 increased GluA1 phosphoryla-
tion in both WT and KO males (Fig. 2C, left panel; two-way ANOVA, treatment effect: F(1,30) = 24.466, 
p < 0.0001). As seen with D1R agonist, despite the higher A2AR/cAMP/PKA signaling in mutants 
compared to treated-controls (p = 0.0026, Fisher’s post-hoc), we failed to find any significant difference 
in fold-induction between genotypes, due to the higher basal p-Ser845-GluA1 levels in KO (Fig.  2C, 
right panel; p = 0.0483, Fisher’s post-hoc). In contrast to what observed in male mutants, lack of Rhes in 
females did not result in altered basal striatal p-Ser845-GluA1 content (Fig. 2B,D, left panel). However, 
in KO females both SKF 81297 and haloperidol administration induced higher p-Ser845-GluA1 levels, 
when compared to WT treated controls (two-way ANOVA, genotype × treatment interaction, SKF 81297: 
F(1,29) = 7.027, p = 0.0129; haloperidol: F(1,32) = 22.383, p < 0.0001). As a consequence, in KO females, 
the comparable basal activity along with an exaggerated phasic D1R- and A2AR-dependent cAMP/
PKA signaling resulted in a greater fold-induction of this pathway (Fig. 2B,D, right panels; SKF 81297, 
p = 0.0175; haloperidol, p = 0.0004). Overall, our findings indicate that lack of Rhes in females, rather 
than influencing the tonic striatal cAMP/PKA activity as seen in male mutants, selectively increases the 
phasic activation of this pathway.
Lack of Rhes does not affect intrinsic membrane properties and corticostriatal long-term 
depression. Based on the strict control of glutamatergic inputs on MSNs activity, we first analyzed 
the striatal AMPAR and NMDAR subunit expression in WT and KO animals. Western blotting analysis 
indicated that protein levels of both NMDAR (GluN1, GluN2A and GluN2B) and AMPAR (GluA1 and 
GluA2/3) subunits are not altered in knockouts of both genders (Fig. 3A,B; p > 0.05, per each protein). 
Next, we examined the effects of Rhes deletion in modulating synaptic properties and plasticity of striatal 
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Figure 1. Rhes mRNA expression in both mouse and human striatal MSNs. (A–C) In situ hybridization 
(ISH) of coronal sections showing Rhes expression along the rostro-caudal extent of the mouse striatum. 
(D–G) Double ISH of mouse caudate/putamen (CPu) using specific antisense riboprobes for Rhes (D,F) 
and Darpp32 (E,G), showing that Rhes is expressed in Darpp32-positive striatal MSNs. Boxed regions 
in (D,E) are shown at higher magnification in both brightfield (F) and fluorescence (G), and neurons 
strongly expressing both Rhes and Darpp32 are indicated by arrows. (H,I), Double ISH analysis of RASD2 
and PPP1R1B expression on cryosections from post-mortem human brain. (H) Nissl stained specimen 
highlighting the neuroanatomical region of the putamen and globus pallidus nuclei. (I) Brightfield 
photomicrograph image of the boxed region in (H) showing co-localizing RASD2 (purple) and PPP1R1B 
(silver grains) mRNA expression in MSNs (arrows). Abbreviations: gp, globus pallidus nucleus; pu, putamen 
nucleus. Scale bar: 2.5 mm (A–C,H); 75 μ m (D,E,I); 15 μ m (F,G).
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MSNs in mutant mice. Based on intracellular and patch-clamp recordings in corticostriatal slices, we 
failed to find any significant difference between genotypes in the intrinsic membrane properties of MSNs 
(Fig.  3C,D, upper panels; Student’s t-test, p > 0.05). Moreover, analysis of activity-dependent synaptic 
plasticity in striatal MSNs revealed that the delivery of a high frequency stimulation (HFS) to corticos-
triatal fibers in presence of Mg2+ (1.2 M) was able to induce comparable long-term depression (LTD) in 
the MSNs of both genotypes, without any evident effect of gender (Fig. 3C,D, bottom panels; two way 
ANOVA, gender effect, male: F(1,136) = 0.71, p > 0.05; female: F(1,136) = 0.41, p > 0.05).
Figure 2. Effect of dopaminergic drugs on striatal cAMP/PKA activity in Rhes male and female mutant 
mice. (A,B) Striatal p-Ser845-GluA1protein levels, in male (A) and female (B) WT and KO mice, following 
5 mg/kg SKF 81297 (WT, n = 9 males, n = 7 females; KO, n = 9 per gender) or vehicle (Veh) treatment 
(WT, n = 9/gender; KO, n = 9 males, n = 8 females) with relative fold-induction. (C,D) Striatal p-Ser845-
GluA1 levels, of male (C) and female (D) WT and KO mice after 0.5 mg/kg haloperidol (Hal) treatment 
(WT, n = 8 males, n = 9 females; KO, n = 9/gender) or Veh (WT, n = 8 males, n = 9 females; KO, n = 9/
gender), with relative fold-induction. Top panels show representative blots comparing the different genotypes 
and treatments. *p < 0.05, **p < 0.01, ***p < 0.0001, compared with Veh-treated group within genotype. 
#p < 0.05, ##p < 0.01, compared with WT group. All data are expressed as mean ± SEM. Genotypes are as 
indicated.
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Figure 3. Intrinsic membrane properties and long-term depression in Rhes mutant mice. (A,B) Western 
blotting analysis on the striatal glutamate AMPAR and NMDAR subunit levels in male (A) (n = 6/genotype 
per GluA1, GluA2/3, GluN1, GluN2B; n = 5 WT, 6 KO per GluN2A), and female (B) (n = 6/genotype 
per GluA1, GluA2/3, GluN2A; n = 4 WT, 5 KO per GluN1; n = 6 WT, 5 KO per GluN2B) mice. The top 
panels show representative blots comparing the different genotypes, for each protein detected. All data are 
expressed as mean ± SEM. Genotypes are as indicated. (C,D) Current-voltage graphs (left) and representative 
traces (right) obtained after applying hyperpolarizing and depolarizing steps of current to MSNs recorded 
from WT (n = 6 males, n = 7 females) and KO (n = 10 per gender) mice. Time-courses (top) and example 
traces (bottom) of the post-synaptic responses measured in MSNs recorded from slices of male KO (n = 6) 
and WT (n = 5) mice (left panel) and female KO (n = 4) and WT (n = 5) mice (right panel), showing no 
difference in high-frequency stimulation (HFS)-induced LTD (Student’s t-test, pre- vs. 30 min post-HFS, 
**p < 0.01).
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Lack of Rhes selectively affects corticostriatal long-term potentiation in A2AR/D2R-positive 
MSNs in a gender-specific manner. Then, we investigated the corticostriatal long-term potentia-
tion (LTP) in male and female mutants. Delivery of HFS to corticostriatal fibers in Mg2+-free medium, 
a condition that favors NMDA receptor activation, was able to induce LTP with comparable amplitude 
and time course in WT and KO male mice (Fig.  4A; two-way ANOVA, genotype effect, F(1,187) = 0.42, 
p > 0.05). Conversely, LTP amplitude was significantly altered in a subpopulation of MSNs recorded from 
mutant females. Specifically, although HFS-induced LTP was similar to controls in 12 out of 27 neurons, a 
complete loss of potentiation was found in the remaining 15 MSNs recorded (Fig. 4B; two-way ANOVA, 
genotype effect, F(2,493) = 30.29, p < 0.001; time × genotype interaction, F(34,493) = 8.71, p < 0.001).
To explain the synaptic plasticity defects found in KO females, we hypothesized that an exaggerated 
phasic cAMP/PKA activation associated to HFS might occlude LTP expression in MSNs that did not 
show any apparent activity-dependent plasticity. To test this idea, low frequency stimulation (LFS) proto-
col was applied to corticostriatal fibers during baseline in striatal slices of WT and KO females. While in 
WT this stimulation protocol did not induce any change in EPSP amplitude, as expected, in KO females 
LFS decreased the EPSP amplitude in 56% of the recorded MSNs. This abnormal synaptic depotenti-
ation seen in female mutants was similar to that observed in control animals after the induction of a 
HFS-dependent LTP29. Further, in KO females, the remaining MSNs (44%) responded with a short-term 
potentiation. (Fig.  4C; two-way ANOVA, genotype effect, F(2,234) = 19.51, p < 0.001; time × genotype 
interaction, F(36,234) = 7.33, p < 0.001).
Finally, given the evidence of a heterogeneous population of striatal MSNs (SP/D1R-expressing direct 
and the A2AR/D2R-expressing indirect pathways)30, we performed post hoc immunohistochemical anal-
ysis to assess the identity of MSNs subtype in KO females not showing any apparent activity-dependent 
LTP. We found that the MSNs that did not respond to HFS with a physiological magnitude of LTP 
in KO females were adenosine A2AR-positive cells that belong to the D2R-expressing striato-pallidal 
pathway (Fig. 4D–F). Moreover, to determine whether circulating ovarian hormones could explain the 
gender-specific dichotomous response to HFS, we analyzed LTP in the MSNs of ovariectomized (OVX) 
KO females. Similar to what observed in intact mutants, HFS of corticostriatal fibers induced LTP only in 
6 out of 12 MSNs recorded from OVX KO females (Fig. 4G; two-way ANOVA, time × genotype interac-
tion, F(17,170) = 4.90, p < 0.001). In addition, no significant difference was found in the striatal expression 
of Estrogen Receptor subunits (ERα and ERβ ) between genotypes (Fig. 4H,I; p > 0.05 per each protein).
Altered striatal LTP in Rhes mutant females in A2AR/D2R-positive neurons is associated to 
exaggerated cAMP/PKA signaling. In light of our biochemical studies, we postulated that the 
excessive phasic cAMP/PKA signaling induced by HFS in female mutants might prevent the normal LTP 
expression in A2AR/D2R-positive MSNs. To verify this idea, we explored in WT and KO female striatal 
slices the consequences of changes in cAMP/PKA activity and A2AR activation on corticostriatal LTP 
expression. As expected, in WT slices patch-clamp recordings of MSNs showed that intrapipette appli-
cation of PKA inhibitor Rp-cAMPs (100 μ M) was able to block LTP31, in all the recorded cells (Fig. 5A), 
confirming that an intact cAMP/PKA activation is required for striatal HFS-induced LTP. In contrast, 
based on the hypothesis that an abnormal high A2AR/cAMP/PKA activity prevented HFS-induced LTP 
in Rhes KO females, we demonstrated that intrapipette application of a PKA inhibitor, at a dose that 
blocked LTP in all the MSNs of WT, was able to normalize synaptic plasticity in SP-negative MSNs (data 
not shown) of mutant females (Fig.  5B; two-way ANOVA, group effect, F(1,170) = 40.53, p < 0.001). We 
next evaluated whether non-physiological A2AR activation in WT could affect the induction of LTP. To 
this aim, bath application of A2AR agonist (CGS21680, 3 μ M) 10 minutes prior to HFS protocol revealed 
the existence of two different subsets of MSNs, one normally responding to HFS with a LTP amplitude 
similar to control, and the other being defective in this form of synaptic plasticity (Fig.  5C; two-way 
ANOVA, group effect, F(2,119) = 12.83, p < 0.01). Therefore, the dichotomous MSNs behaviors under 
A2AR agonist strengthened the idea that, differently from SP/D1R-positive MSNs, non-physiological 
increase of cAMP/PKA signaling in A2AR/D2R-bearing neurons prevents its activity-dependent plas-
ticity, as seen in Rhes KO females.
To further assess the role of A2AR activation on striatal LTP expression, we recorded the effects of 
the A2AR antagonist ZM241385 (1 μ M) in WT slices. Intracellular and patch-clamp recordings showed 
that following blockade of A2AR, LTP was induced only in SP/D1R-positive MSNs (Fig.  5D). In con-
trast, the remaining A2AR/D2R-positive MSNs, which not responded with LTP, paradoxically showed 
a LTD (Fig. 5D; two-way ANOVA, group effect, F(1,272) = 26.78, p < 0.001). Similar to what observed in 
WT slices, application of ZM241385 in KO females did not affect a regular HFS-induced LTP in SP/
D1R-positive MSNs (Fig.  5F). In contrast, ZM241385 in A2AR/D2R-positive MSNs (Fig.  5G) of KO 
females failed to induce LTD (Fig. 5E; two-way ANOVA, group effect, F(1,408) = 28.27, p < 0.001), unlike 
reported in controls.
Rhes mutants display altered motor responses to dopamine and adenosine drugs in a 
gender-specific fashion. Here we investigated the gender effect of Rhes deletion on behavioral 
responses induced by DA and adenosine drugs. At all doses tested, the DA D1R agonist, SKF 81297, sim-
ilarly enhanced horizontal motor activity in males of both genotypes (Fig. 6A; three-way ANOVA with 
repeated measures, treatment effect: 1.25 mg/kg, F(1,335) = 33.633, p < 0.0001; 2.5 mg/kg, F(1,415) = 86.567, 
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Figure 4. Long-term potentiation in MSNs of Rhes mutant mice and morphological characterization. 
(A) Time-course plots of EPSP amplitude (left) and pairs of traces (right) demonstrate the presence of 
HFS-induced LTP in MSNs recorded from slices of male WT (n = 5) and KO (n = 7) mice (Student’s t-test, 
pre- vs. 30 min post-HFS, **p < 0.01). (B) Time course graphs of the EPSC amplitude (left) and pairs of 
traces (right) show the induction (n = 12) or the complete loss (n = 15) of LTP in MSNs from female KO 
mice compared with age-matched WT animals (n = 5) (Student’s t-test at 30 min post-HFS, WT vs. KO with 
LTP, p > 0.05, WT vs. KO with no LTP, ***p < 0.001). (C) In KO females application of a low-frequency 
stimulation (LFS) induced a decrease of EPSP amplitude in 5 of 9 MSNs recorded and a mild potentiation 
in the remaining 4 MSNs, whereas the same protocol induced no change of synaptic activity in all the 
MSNs (n = 7) recorded from WT females (Bonferroni post-hoc: WT vs. KO with LTP, *p < 0.05; **p < 0.01; 
***p < 0.001; Student’s t-test at 30 min post-HFS: WT vs. KO with a depression of EPSP, ***p < 0.001). 
(D–F) Confocal laser scanning microscopy (CLSM) images of double-labeled immunofluorescence for 
biocytin and adenosine receptor (A2AR). Biocytin immunolabeling is visualized in red streptavidin-Cy3 
immunofluorescence (D) and A2AR is visualized in green Cy2 immunofluorescence (E). The colocalization 
of A2AR and biocytin is showed in merged panel (F) as yellow fluorescence. (G) HFS protocol applied in 
the MSNs of ovariectomized (OVX) KO females induced LTP in 6 of 12 MSNs recorded (Student’s t-test 
at 30 min post-HFS: WT vs. KO OVX with no LTP, *p < 0.05). (H,I) Striatal ERα and ERβ , determined by 
Western blotting, in WT and KO male (n = 6 /genotype per ERα ; n = 6 WT, 5 KO per EPβ ) (H) and female 
(n = 5 WT, 6 KO per ERα ; n = 6 /genotype per ERβ ) (I) mice. The top panels show representative blots 
comparing the different genotypes. All data are expressed as mean ± SEM. Genotypes are as indicated.
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Figure 5. Altered striatal LTP in Rhes KO females associated to exaggerated A2AR/cAMP/PKA 
signalling. (A) The LTP of the MSNs recorded with intrapipette application of PKA inhibitor Rp-cAMPs 
was blocked in all the recorded cells ( n = 4) (Student’s t-test at 30 min post-HFS: WT in Rp-cAMPs, pre vs 
post HFS, p > 0.05). (B) LTP induction in MSNs of KO females recorded with intrapipette application of Rp-
cAMPs (Student’s t-test at 30 min post-HFS: KO with no LTP, n = 7, vs. KO with LTP, n = 5, ***p < 0.001). 
(C) bath application of A2AR agonist CGS21680 in slices from WT females revealed the existence of two 
different subsets of MSNs showing LTP and no LTP (Student’s t-test at 30 min post-HFS: WT with no 
LTP, n = 5, vs. WT with LTP, n = 4, ***p < 0.001). (D) A2AR antagonist ZM241385 bath applied in slices 
of WT females induces LTP in n = 12 cells and LTD in the remaining n = 6 neurons (Student’s t-test at 
30 min post-HFS: WT with LTD vs. WT with LTP, ***p < 0.001). (E) ZM241385 application in KO neurons 
induced a regular LTP (n = 16) in SP/D1R-positive MSNs and no change (n = 10) in A2A/D2R-positive 
MSNs (Student’s t-test at 30 min post-HFS: KO with no LTP vs. KO with LTP, ***p < 0.001). (F,G) Confocal 
laser-scanning microscopy images of triple-labeled immunofluorescence for biocytin, SP and D2 receptor. 
SP is visualized in green, D2R is visualized in light blue-Cy5 fluorescence and biocytin immunolabeling is 
visualized in streptavidin-Cy3 fluorescence, the merged image is shown on the bottom right of the panels.
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p < 0.0001). Likewise, SKF 81297 treatment in females also induced hyperlocomotion in both geno-
types at either dose tested (Fig.  6B; 1.25 mg/kg, F(1,330) = 10.644, p = 0.0018; 2.5 mg/kg, F(1,390) = 14.095, 
p = 0.0003). However, female mutants showed a significant higher hyperactivity at 2.5 mg/kg drug dose 
(genotype effect, F(1,390) = 5.456, p = 0.0221), compared to control treated animals.
Next, we analyzed the effect of the DA D2R antagonist haloperidol, on catalepsy. We found no major 
treatment effect in males following 0.1 mg/kg drug administration in both genotypes (Fig. 6C). On the 
other hand, both 0.25 and 0.5 mg/kg haloperidol administration induced a higher cataleptic response 
in male KO mice, compared to WT (Fig.  6C; two-way ANOVA, genotype effect, 0.25 mg/kg, males, 
Figure 6. D1R and A2AR-dependent behavioral responses in Rhes mutant mice.  
(A,B) Locomotor activity induced in male (A) and female (B) WT and KO mice by SKF 81297 (1.25 mg/kg: 
WT, n = 15 males, n = 14 females; KO, n = 13 males, n = 14 females; 2.5 mg/kg: WT, n = 21 males, n = 21 
females; KO, n = 23 males, n = 19 females) or in Veh-treated group (WT, n = 21/gender; KO, n = 22 males, 
n = 21 females). (C,D) Cataleptic effect of Hal in male (C) and female (D) WT and KO mice (0.1 mg/kg: 
n = 8/genotype and gender; 0.25 mg/kg: n = 8/genotype and gender; 0.5 mg/kg: WT, n = 13 males, n = 8 
females; KO, n = 13 males, n = 8 females) or Veh-treated group (WT, n = 8 males, n = 5 females; KO, n = 8 
males, n = 5 females). *p < 0.05, **p < 0.01, compared with Hal-treated WT mice. (E) Effect of adenosine 
A2AR blockade by CSC treatment (2.5 mg/kg) on haloperidol-dependent catalepsy in female WT and KO 
mice. Animals were treated with CSC plus Hal (WT, n = 7; KO, n = 6) or Hal (WT, n = 7; KO, n = 6) and 
analyzed 60 min after haloperidol injection. **p < 0.01, compared with Hal-treated group. (F,G) Locomotor 
activity in male (F) and female (G) WT and KO mice induced by caffeine 7.5 mg/kg (WT, n = 11 males, 
n = 18 females; KO, n = 12 males, n = 18 females), compared to Veh-treated mice (WT, n = 10 males, n = 11 
females; KO n = 10/gender). All data are expressed as mean ± SEM. Genotypes are as indicated.
www.nature.com/scientificreports/
1 0Scientific RepoRts | 5:10933 | DOi: 10.1038/srep10933
F(1,28) = 5.145, p = 0.0397; 0.5 mg/kg, males, F(1,48) = 16.561, p = 0.0004). In contrast, in female mutants 
we found higher haloperidol-induced cataleptic responses at all doses tested, including the lowest one 
(Fig.  6D; two-way ANOVA, 0.1 mg/kg, F(1,28) = 4.685, p = 0.0482; 0.25 mg/kg, females: F(1,28) = 43.967, 
p < 0.0001; 0.5 mg/kg, F(1,28) = 21.012, p = 0.0004).
Since activation of striatal adenosine A2AR positively modulates haloperidol-induced catalepsy32, we 
examined the effect of A2AR blockade on the exaggerated cataleptic response seen in female KO mice. 
Strikingly, pre-administration of the A2AR antagonist, 8-(3-Chlorostyryl)-caffeine (CSC), was able to 
normalize catalepsy in mutant females (Fig.  6E; two-way ANOVA, genotype × treatment interaction: 
F(1,22) = 4.305, p = 0.0499).
Finally, considering that caffeine motor stimulation mainly relies on A2AR antagonism33,34, we ana-
lyzed its psychoactive properties in Rhes mutants. In line with enhanced A2AR response, administration 
of caffeine produced an overall significant higher hyperactivity in mutants of both genders (Fig.  6F,G, 
three-way ANOVA with repeated measures, males, F(1,473) = 10.494, p = 0.0023; females, F(1,583) = 7.140, 
p = 0.01), compared to their respective WT treated group.
Striatal medial-to-lateral gradient of Rhes mRNA resembles those of A2AR and D2R. To 
understand why the lack of Rhes impacts more profoundly on behavioral A2AR- and D2R-mediated 
responses, rather than those regulated by D1R, we compared the expression profile of Rhes mRNA to that 
of A2AR, D2R and D1R in the striatum of WT mice. Results showed a clear medial-to-lateral gradient of 
Rhes mRNA along the antero-posterior extent of the caudate/putamen (CPu) (Fig. 7A,E), which mirrored 
that of A2AR and D2R (Fig. 7B,C,F,G). Densitometric quantification of autoradiograms within the four 
quadrants in which the striatum was subdivided (namely, Dorso-Medial, Ventro-Medial, Ventro-Lateral, 
Dorso-Lateral) confirmed that Relative Optical Density (ROD) was significantly higher in the Dorso- 
and Ventro-Lateral quadrants as compared to the medial counterparts (Fig. 7I). Conversely, D1R mRNA 
appeared uniformly distributed within the four quadrants of the CPu nucleus (Fig. 7D,H,I).
Finally, in order to exclude that enhanced magnitude of motor responses to haloperidol and caffeine 
in mutants were linked to altered striatal A2AR receptor occurrence, we next assessed whether Rhes 
inactivation could influence A2AR mRNA and proteins expression levels. Notably, quantification analy-
ses from neither radioactive ISH nor Western blot experiments showed significant differences of A2AR 
mRNA or protein levels between genotypes and genders (Fig. 7J–M, Student’s t-test) p > 0.05, per each 
protein, .
Lack of Rhes does not affect hippocampal long-term potentiation. In addition to striatum, 
Rhes mRNA expression is also seen in both murine and human hippocampus (Fig. 8A), but its role in 
hippocampal LTP is unclear. Rhes was expressed in the granule cell layer of the dentate gyrus (DG) and 
in the pyramidal cell layer of Ammon’s horn (Fig.  8A,b–d). Autoradiographic images using radioac-
tive 35S ISH also showed expression of RASD2 in the hippocampal formation of human brain samples 
(Fig. 8A,f). At high magnification, we observed autoradiographic grains on the granule cells of the DG 
and in the hilus (Fig. 8A,g,h). Pyramidal neurons of fields CA3, CA2, and CA1 of Ammon’s horn and 
the subiculum were also specifically labeled (Fig. 8A,i–l).
To determine whether alterations of striatal LTP in KO mice were area-specific or a widespread phe-
nomenon associated to lack of Rhes, we measured basal synaptic transmission, short-term plasticity and 
LTP at CA1 hippocampal synapses in Rhes mutants (Fig. 8B,C). Overall, differences in the input-output 
relationship (p > 0.05 for all stimulation intensities) and in the paired-pulse ratio (p > 0.05 at all 
inter-pulse intervals) were not observed either in male (Fig. 8B) or female (Fig. 8B) mutants. In addition, 
theta-burst stimulation (TBS) (Fig.  8B,C), delivered to Schaffer collateral fibers, produced comparable 
levels of CA1-LTP in male (fEPSP amplitude at 60 min post-TBS: WT 155 ± 10%; KO 146% ± 7%, left 
panel) and female KO mice when compared to gender-matched controls (fEPSP amplitude at 60 min 
post-TBS: WT 146% ± 9%; KO 143% ± 12%; right panel). Indeed, two-way ANOVA confirmed no sig-
nificant effect of gender (F(1,16) = 0.146, p > 0.05) or genotype (F(1,16) = 0.125, p > 0.05). Thus Rhes pre-
dominantly affects synaptic plasticity associated with striatum.
Discussion
In the present work, we studied how lack of Rhes influences the striatal cAMP/PKA signaling-related 
synaptic and behavioral responses under both basal and challenged conditions, in a gender-dependent 
manner. We analyzed a Rhes KO mouse line25, in which the PGK-neo cassette had been removed in order 
to avoid any potential interference on gene transcriptional regulation35–37. In accordance with previous 
data2, we report that lack of Rhes does not affect basal motor abilities in both male and female mutant 
mice (data not shown). Similarly, electrophysiological data revealed that Rhes mutant mice display no dif-
ference in intrinsic and synaptic basal properties of striatal MSNs, when compared to controls. Moreover 
we did not find any apparent alteration in striatal LTD between genotypes in both genders.
Conversely, lack of Rhes was found to be critical in the expression of striatal MSNs LTP in a 
gender-sensitive manner. Consistently, while WT and KO males display similar LTP, in females only in 
a subset of D1R-positive MSNs we recorded comparable LTP amplitudes between genotypes. Based on 
the knowledge that LTP is a form of corticostriatal plasticity that requires intact cAMP/PKA signaling31, 
the inability of certain MSNs to potentiate EPSP amplitude in response to HFS apparently contradicts 
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the greater striatal cAMP-PKA signaling found in Rhes mutant females. To explain such discrepancy, we 
hypothesized that the apparent loss of LTP in mutants might be generated by an exaggerated increase 
in PKA activity, which in turn leads to constitutive saturated LTP. Consistent with this idea, in mutant 
females, LFS protocol of corticostriatal fibers during baseline transmission causes significant “depoten-
tiation” or mild potentiation in a ratio that reflects the proportion of MSNs responding to HFS with a 
lack of LTP or with a LTP expression similar to control, respectively.
Several striatal responses in animals and humans are affected by gender through the action of various 
factors, including circulating estrogens38–40. Therefore, we evaluated the potential involvement of this 
these sexual hormones in the expression of altered synaptic plasticity seen in female mutants. Overall, 
electrophysiological experiments excluded a direct implication of estrogens in determining the LTP 
defects as we confirmed in OVX mutants the existence of two independent striatal subpopulations of 
MSNs that either express LTP or undergo a saturated state. In addition, we also ruled out an altered 
estrogen receptor expression level as the cause for defective LTP, as striatal levels of ERα and ERβ are 
comparable between genotypes.
In order to identify the receptor specificity of the MSNs fraction in which LTP is saturated in KO 
females, we performed staining experiments after patch-clamp recordings. Remarkably, in Rhes mutants 
we found that striatal MSNs that did not express LTP are selectively A2AR/D2R-positive. Thus, in line 
with the notion that non-physiological phasic A2AR/cAMP/PKA responses found in female mutants 
Figure 7. Medial-to-lateral expression gradient of Rhes, A2AR and D2R in the mouse CPu.  
(A–H) Representative pseudocolor autoradiographs from coronal section of mouse brain showing medial-
to-lateral expression gradient of (A,E) Rhes mRNA, (B,F) A2AR and (C,G) D2R. (D,H) D1R mRNA appears 
uniformly distributed. (I) Histogram showing quantification of Rhes, A2AR, D2R and D1R mRNA expression 
levels obtained after densitometric quantification of autoradiograms. Differences are expressed  
as percentage of variation compared with the signal mesured in the dorsomedial part of the CPu.  
(J–M), A2AR levels were determined by radioactive ISH (n = 3/genotype for both genders; J,L) and in  
total striatal extracts by Western blot, in naïve male (n = 6/genotype; K) and female (n = 6/genotype;  
M) mice. The top panels show representative blots comparing the different genotypes. All data are expressed 
as mean ± SEM. *p < 0.05, **p < 0.01. Scale bar: 750 μ m
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Figure 8. Expression pattern of Rhes and RASD2 mRNA in mouse and human hippocampus.  
(A)(a–d), In situ hybridization experiment on a coronal section of mouse brain showing Rhes expression in 
hippocampus. Boxed regions in (a) are shown at higher magnification in (b; dentate gyrus, DG, and hilus), 
(c; CA3) and (d; CA1). (e-l), Nissl staining (e) and radioactive (35S) ISH analysis (f–l) showing expression 
of RASD2 in the hippocampus in a representative section from post-mortem human brain. RASD2 
autoradiographic signal is present in the dentate gyrus (g; DG), hilus (h), CA3 (i), CA2 (j), CA1 (k), and 
subiculum (l). Scale bar: 1.3 mm (a); 60 μ m (b–d, g–l); 1.8 mm (e,f). (B,C) Input/output relationship (left 
panel) and paired pulse (PP) ratios (center panel) obtained from CA1 area in WT and KO male (B) and 
female (C) mice. Each group represents n = 6 mice. Superimposed pooled data (right panel) representing 
normalized changes in the field potential amplitude (fEPSP) (± SEM) induced by TBS between male WT 
(n = 6) and KO (n = 4) mice (B, right panel) and female WT (n = 5) and KO (n = 5) mice (C, right panel).
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may occlude activity-dependent LTP, we revealed that PKA inhibitor strikingly restores LTP in A2AR/
D2R-positive KO MSNs. Moreover, we found that A2AR agonist application unmasks in WT striatum 
the existence of two different subsets of MSNs, one not affected by such manipulation that responded to 
HFS with a regular LTP, and another population of neurons, sensitive to A2AR stimulation, that fails to 
express a physiological LTP magnitude.
Altogether, this set of pharmacological experiments on slices from WT female striata reproduces the 
findings obtained in Rhes mutants and, in turn, demonstrates that A2AR activity drives the direction of 
corticostriatal plasticity in striato-pallidal pathway by regulating the magnitude of cAMP/PKA activity. 
In accordance to the consistent role of A2ARs in determining a physiological LTP in striato-pallidal neu-
rons41, pharmacological blockade of these receptors with ZM241385 prevents HFS-induced LTP, trigger-
ing an unexpected LTD induction in WT slices. An explanation for this switch in synaptic plasticity likely 
relies on the ability of A2AR inhibition to unmask a higher D2R- mediated signaling which, in turn, 
favors LTD expression42. In contrast to what observed in WT, we report that ZM241385 administration 
in KO females prevents any form of synaptic plasticity in A2AR/D2R-expressing MSNs. This suggest that 
lack of LTD response in Rhes KO striata can be explained by previous results of our group demonstrating 
that D2R activity, as measured by GTP gamma assay, is slightly compromised in Rhes KO2.
It is well established that A2AR transmission exerts a pivotal role in modulating the magnitude of 
haloperidol-induced catalepsy and caffeine-triggered hyperactivity32–34. Therefore, in line with an exac-
erbated A2AR-mediated signaling in Rhes KO, we found significant higher haloperidol-induced cata-
lepsy and caffeine-induced motor simulation responses, when compared to gender-matched controls. 
Although more pronounced in females, enhanced behavioral responses to haloperidol and caffeine also 
occurs in Rhes KO males when compared to their sex-matched treated controls. These in vivo observa-
tions suggest that, differently to striatal LTP and DA D1R-dependent motor stimulation, lack of Rhes 
affects striato-pallidal-dependent behaviors with a less prominent gender-sensitive influence. Although 
we reported that Rhes mRNA medial-lateral expression gradient strictly resembles that of A2AR and 
D2R, we exclude that abnormal striato-pallidal responses seen in mutants are associated to different 
A2AR expression since striatal mRNA and protein levels were comparable between genotypes. We also 
show that Rhes mRNA is expressed not only in striatal Darpp32-positive MSNs of rodents and humans, 
but also in various hippocampal regions. In keeping with this evidence, we demonstrated that hippocam-
pal LTP induction in the CA1 region is unaffected in both genders of mutants, thus strengthening the 
sex-specific role of Rhes in modulating synaptic plasticity selectively in striatal MSNs. Furthermore, 
cognitive functions analyzed by object recognition and fear conditioning tasks are comparable between 
KO and WT mice of both genders (data not shown).
Extending our previous work2, the present study indicates that lack of Rhes differently impacts 
on striatal cAMP/PKA signaling in a gender specific fashion, causing a significant basal increase in 
males while generating a higher response in females, selectively under challenge conditions. In light of 
a gender-sensitive regulation of cAMP/PKA activity and consistent with a crucial involvement of this 
signaling pathway in modulating D1R-, D2R- and A2AR-mediated behavioral responses, we explain 
the sex-related differences in response to SKF81297, haloperidol and caffeine found in KO mice, when 
compared to their matched-controls.
Similarly, we argue that the striking gender-related difference in LTP expression found in A2AR/
D2R-positive MSNs of mutants depends on the different magnitude of cAMP/PKA signaling triggered by 
HFS protocol in male and females. Therefore, we propose that yet unknown factors, other than estrogens, 
should be directly or indirectly involved in the regulation of striatal cAMP/PKA activity underlying the 
gender specific LTP expression found in Rhes KO.
Altogether our findings, indicating that Rhes plays a crucial gender-specific role in orchestrating 
striatal-dependent behaviors, increase the functional complexity of this GTP binding protein function.
In addition, considering the enhanced haloperidol-induced catalepsy and caffeine-triggered motor 
hyperactivity in mutants, we propose that Rhes could emerge as a novel thyroid hormone-target gene to 
investigate the molecular and cellular determinants associated to the use of these substances in humans.
Methods
Animals. In order to prevent the possibility that the presence of the PGK-neo cassette may inter-
fere with normal transcriptional regulation within the Rhes locus35–37,43, we crossed Rhes+/loxP-neo  
offspring25 with a CMV-Cre deleter strain in a B6D2 genetic background44. The validation of 
Cre-mediated loxP-flanked neo cassette excision was assessed by PCR analysis using the following 
primers: Rhes-EGFP_forward: 5′ -CATGGTCCTGCTGGAGTTCGTGA-3′ , and Rhes-Ex2_reverse: 
5′ -ACCACCATGCGGTAGGAGTTCT-3′ . The amplification product was ~400 bp. Mice obtained were 
then genotyped by PCR using the following primers: Rhes-forward 5′ -TTTAGGAATTTCACCTGTGT-3′ 
and Rhes-Ex2_reverse 5′ -ACCACCATGCGGTAGGAGTTCT-3′ , for Rhes+/+(WT) allele (420 bp); 
Rhes-EGFP_forward 5′ -CATGGTCCTGCTGGAGTTCGTGA-3′ and Rhes Ex2_reverse: 5′ ACCACCATG 
CGGTAGGAGTTCT-3′ for Rhes−/− (KO) allele (370 bp). KO mice were viable, fertile and did not show 
alteration in body weight and basal motor activity (data not shown). Ten- to twelve-week-old male 
and female WT and KO mice, derived from mating of heterozygous animals (Rhes+/−), back-crossed 
to F11 generation to C57BLJ/6 strain, were used in this study. Mice were housed in groups in standard 
cages (29 × 17.5 × 12.5 cm) at constant temperature (22 °C ± 1 °C) and maintained on a 12/12 h light/
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dark cycle, with food and water ad libitum. Experiments were performed in conformity with protocols 
approved by the veterinary department of the Italian Ministry of Health and in accordance to the ethical 
and safety rules and guidelines for the use of animals in biomedical research provided by the relevant 
Italian laws and European Union’s directives (n. 86/609/EC). All efforts were made to minimize the 
animal’s suffering.
Ovariectomy. In females of 2 months of age, after anaesthesia, the lumbar dorsum was shaved, and 
the exposed skin prepared for septic surgery (a 10% povidene–iodine scrub followed by a sterile saline 
wipe). The procedure was performed according to a previously published protocol45 with minor modifi-
cations46. For details see Supplementary Materials.
Human samples. Human tissue was obtained from the Brain and Tissue Bank for Developmental 
Disorders at the University of Maryland, Baltimore. Samples for cryosectioning were dissected in the 
region of the putamen nucleus and hippocampus of brains from one male (16 years old, 16 h post-mortem) 
and one female (35 years old, 6 h postmortem) who had no history of primary neurological or psychiatric 
disorders and processed as previously described47.
In situ hybridization (ISH). ISH analysis was performed according to protocols previously described48. 
Digoxigenin (DIG) (Rhes, 0.5 Kb; RASD2, 2.8 Kb), fluorescein- (Darpp32, 0.6 Kb), or 35S-labelled 
(PPP1R1B, 1.5 Kb; RASD2, 2.8 Kb; Rhes, 0.5 Kb; A2AR, 1.2 Kb; Drd2, 1.0 Kb Drd1, 0.3 Kb) antisense ribo-
probes were used. Detailed sequences used for each probe are the following: RASD2, nucleotides 178–
2971 (NM_014310.3); Darpp32, nucleotides 144–685 (NM_144828.1); PPP1R1B, nucleotides 23–1500 
(NM_181505.3); A2AR, nucleotides 521–1736 (NM_009630.3); D1R49; D2R49; Rhes25. For double ISH on 
mouse tissue, sections were hybridized simultaneously with DIG- and fluorescein-labelled riboprobes. A 
two-step chromogenic reaction using NBT/BCIP and HNPP/Fast Red Fluorescent Detection Set (Roche) 
was performed to visualize the DIG- and fluorescein-labelled riboprobes, respectively. Specimens were 
counterstained with DAPI. For radioactive ISH, hybridized sections were exposed to Biomax MR X-ray 
films (Kodak) for two to four days. For each probe used, sections from different genotypes and gender 
were processed in parallel in order to minimize the experimental variability. Double-ISH on human 
tissue was performed combining DIG-labelled and35 S-radiolabelled riboprobes. After chromogenic reac-
tion using NBT/BCIP for the detection of the DIG-labelled riboprobe, slides were dipped in Kodak NTB 
emulsion for autoradiography as previously described47. Sections were examined using brightfield and 
darkfield light microscopy.
Image analysis and quantification. Quantification analyses were performed in blind and sample 
identity was not revealed until correlations were completed. For densitometric analyses, 15–20 sections 
per animal along the whole rostro-caudal extent of the striatum were used and images of autoradiography 
films resulting from radioactive ISH experiments were scanned at a resolution of 1200 dpi. For the analy-
sis of Rhes, A2AR, D2R and D1R mRNA expression in the striatum of WT animals the Caudate-Putamen 
(CPu) was divided into four quadrants, dorso-medial (DM), dorso-lateral (DL), ventro-medial (VM) and 
ventro-lateral (VL), accordingly to Harrison and LaHoste, 20068. Optical Density (OD) for each gene 
analyzed was evaluated in the four areas of the striatum. Background OD value was determined in struc-
tures of the same section devoid of specific signal and subtracted for correction to obtain the Relative OD 
(ROD) value. Results were expressed as percentage increase/decrease of mRNA-expression in the DM 
for each probe. Data were analyzed by Student’s t-test. For the analysis of A2AR mRNA expression ROD 
was evaluated in whole striatum of WT and KO adult male and female mice. Results were expressed as 
percentage increase/decrease of A2AR mRNA-expression. Analysis was performed by using StatView 
software (version 5.0.1.0; SAS Institute).
Electrophysiological recordings from medium spiny neurons (MSNs). The preparation 
and maintenance of coronal corticostriatal slices have been previously described50. For details see 
Supplementary Materials.
Intracellular recordings with sharp electrodes. For the long-term potentiation (LTP) protocol, at the 
beginning of intracellular recordings, magnesium ions were omitted from the medium to increase the 
N-methyl-D-aspartate (NMDA)-mediated component of excitatory post-synaptic potential (EPSP). As 
conditioning high frequency stimulation (HFS) protocol to induce either long-term depression (LTD) 
or LTP we used three trains (3 seconds duration, 100 Hz, 20 seconds intertrain interval). During tetanic 
stimulation, the intensity was increased to suprathreshold levels. To induce depotentiation, low frequency 
stimulation (LFS) protocol (2 Hz, 10 min of total duration) was used as previously shown29,51.
Whole-cell patch-clamp recordings. Patch-clamp recordings were performed as previously shown50,52. 
Quantitative data on EPSP modifications induced by HFS are expressed as a percentage of the controls, 
the latter representing the mean of responses recorded during a stable period (15–20 min) before the 
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HFS. Current–voltage relationships were obtained by applying steps of current of 50 pA in both hyper-
polarizing and depolarizing direction (from − 600 to 400 pA). Statistical analysis was performed using 
Prism 4.0 (GraphPad). Student’s t-test was used to compare data within group pre vs. 30 min post-HFS. 
Group comparisons were analyzed with two-way ANOVA. When a significant interaction was observed 
the data were further analyzed with Bonferroni post-hoc test.
Extracellular recordings in the hippocampus. Hippocampal slices were prepared as previously 
described53. A single slice was placed on a nylon mesh, completely submerged in a small chamber 
(0.5 ml) and superfused with oxygenated artificial cerebrospinal fluid (ACSF) at a constant flow rate 
of 3 ml/min. A bipolar tungsten stimulating electrode was positioned in the CA1 stratum radiatum to 
stimulate the Schaffer collateral fibers, and extracellular field excitatory post-synaptic potentials (fEPSPs) 
were recorded with a glass microelectrode (2–3 MΩ ) in the stratum radiatum. LTP was evoked by theta 
burst stimulation (TBS) protocol consisting of 4 trains of 5 pulses at a frequency of 100 Hz, with an 
inter-train interval of 200 ms. All data are presented as mean ± SEM and n indicates the number of slices. 
Statistical analysis was performed by two-way ANOVA with gender and genotype as between subject 
factors. Statistical significance was set at p < 0.05.
Tissue processing and double immunofluorescence of striatal MSNs. Tissue processing 
and double immunofluorescence were performed according to protocols previously described52. See 
Supplementary Materials for detailed information.
Behavior. Drug-induced motor responses. Mice were randomly assigned to 1.25, 2.5 mg/kg SKF 81297 
or vehicle (Veh)-treated groups, habituated to the experimental cage (35 × 25 × 30 cm) for 60 min, and 
then injected with drug or Veh and placed in the same cage, as previously described49. The horizontal 
motor activity was evaluated during 10-min intervals over a 1 h-test session, through a computerized 
video tracking system (Videotrack, Viewpoint S.A., Champagne au Mont d’Or, France). The effect of 
SKF 81297 on locomotor activity (expressed in cm) was used as dependent variable and analyzed by 
three-way (genotype × treatment × time) ANOVA with repeated measures.
Caffeine-induced locomotor hyperactivity was performed according to a previously validated pro-
tocol34. Briefly, WT and KO animals were randomly assigned to caffeine (7.5 mg/kg), or Veh-treated 
groups. The horizontal motor activity was evaluated during 10-min intervals over a 2 h-test session. 
Effect of caffeine on locomotor activity (expressed in cm) was used as dependent variable and analyzed 
by three-way (genotype × treatment × time) ANOVA with repeated measures.
Catalepsy. Catalepsy in mice was assessed according to a previous protocol2. To evaluate the 
haloperidol-induced cataleptic response, 60 min before drug treatment WT and KO mice of both gen-
ders were placed one per cage for adapting to the new environment. Animals were randomly grouped 
to be treated, respectively, with 0.1, 0.25, 0.5 mg/kg haloperidol (Hal) or vehicle (Veh). Catalepsy was 
measured 30, 60 and 120 min after drug or vehicle injection, by gently placing the front limbs of the 
animals over a 4 cm-high horizontal bar. The intensity of catalepsy (expressed in s) was assessed by 
measuring the time each mouse remained with limbs completely immobile for a maximum of 300 s. 
Data were analyzed between genotypes, at each haloperidol dose tested, by two-way (time × genotype) 
ANOVA with repeated measures. Other independent groups of female mice were used to assess the effect 
of 8-(3-Chlorostyryl)-caffeine (CSC) in haloperidol-induced catalepsy, according to Chen et al.32. Mice 
were co-administered with Veh plus 0.5 mg/kg haloperidol or haloperidol plus 2.5 mg/kg CSC (adminis-
tered 10 min before haloperidol injection). Catalepsy was evaluated 60 min after treatment and analyzed 
by two-way ANOVA, followed by Fisher’s post-hoc comparison.
Western blotting. Male and female mice of both genotypes were treated with 5 mg/kg SKF 81297, 
0.5 mg/kg haloperidol (Hal) or Veh, and killed by decapitation 30-min later, according to a previous 
protocol49. Normalized values of phospo-GluA1 at residue Ser845 levels were averaged and used as 
dependent variable. Data were analyzed between genotypes by two-way (treatment × genotype) ANOVA, 
followed by Fisher’s post-hoc comparison, when required. Striatal levels of glutamate NMDAR (GluN1, 
GluN2A, GluN2B), AMPAR (GluA1, GluA 2/3) subunits, as well as estrogen (α and β ) and adenosine 
(A2AR) receptors, were analyzed in naïve WT and KO animals of both genders. Normalized values of 
each target were used as dependent variable and analyzed between genotypes by Student’s t-test. For 
detailed information see Supplementary Materials.
All behavioral and biochemical values are expressed as mean ± SEM. Statistics analyses were based 
on parametric tests as the data were normally distributed. Normality was checked with Shapiro-Wilk 
test (p < 0.05).
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